1,877
Views
12
CrossRef citations to date
0
Altmetric
Bedside to Bench Reports

Metformin: a modulator of bevacizumab activity in cancer? A case report

, , , , , , & show all
Pages 210-214 | Received 22 Oct 2014, Accepted 18 Dec 2014, Published online: 10 Mar 2015

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.